The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).

VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.

BTOG 2022 Summer Meeting | The use of synthetic control arms to evaluate patients with rare oncogene-driven subsets in NSCLC

Name: The use of synthetic control arms to evaluate patients with rare oncogene-driven subsets in NSCLC
Uploaded: 2022-07-08T00:00:00Z
Duration: 1 min 52 s
Description: Sanjay Popat, PhD, MBBS, FRCP, Royal Marsden NHSFT/BTOG Steering Committee, UK, discusses the use of real-world synthetic control arms to investigate rare oncogene-driven subsets in non-small cell lung cancer (NSCLC). This interview took place at the BTOG 2022 Summer Meeting congress in London.

Sanjay Popat • 8 Jul 2022

BTOG 2022 Summer Meeting

Lung Cancer Non-Small Cell Lung Cancer

Sanjay Popat, PhD, MBBS, FRCP, Royal Marsden NHSFT/BTOG Steering Committee, UK, discusses the use of real-world synthetic control arms to investigate rare oncogene-driven subsets in non-small cell lung cancer (NSCLC). This interview took place at the BTOG 2022 Summer Meeting congress in London.